Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7 (Q67589700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

F. J. Kos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446709

27 September 2022

A. Müllbacher

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446709

27 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1446709

27 September 2022

publication date

1 December 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

3183-3185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Synthetic peptides: a next generation of vaccines?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Synthetic peptides as the basis for vaccine design

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

In vitro primary induction of cytotoxic T cells against virus-infected syngeneic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Peptide-induced antiviral protection by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830221224

7 January 2021

Identifiers

DOI

10.1002/EJI.1830221224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446709%20AND%20SRC:MED&resulttype=core&format=json